Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

NCT01281852 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Cervical Squamous Cell Carcinoma, Not Otherwise Specified
Recurrent Cervical Carcinoma
Stage IVB Cervical Cancer AJCC v6 and v7

Interventions

DRUG: Cisplatin
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
DRUG: Veliparib

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]